125 Participants Needed

Minimally Invasive Right Hemicolectomy for Colorectal Disorders

(RICART Trial)

PM
KV
HR
JK
kS
JR
Overseen ByJulia Reish
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Spectrum Health Hospitals
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores the best method for performing a minimally invasive right hemicolectomy, a surgery to remove part of the colon for individuals with certain colorectal issues. Researchers compare two surgical techniques: intra-corporeal anastomosis (reconnecting the intestine inside the body) and extra-corporeal anastomosis (reconnecting it outside the body). The aim is to determine which method is more effective and results in fewer complications. The trial seeks adults scheduled for this specific surgery who are not undergoing additional colon surgeries simultaneously. As an unphased trial, it offers patients the chance to contribute to improving surgical techniques and outcomes.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this minimally invasive technique is safe for right hemicolectomy?

Research has shown that joining two parts of the intestine inside the body, known as intra-corporeal anastomosis, is a safe option for those undergoing minimally invasive surgery to remove part of the colon. Studies have found this method to be as safe as joining outside the body, with additional benefits.

One study found that patients who underwent the inside-the-body method experienced similar short-term results compared to those who had the outside-the-body method. Importantly, both methods had similar complication rates. Another study noted that the inside-the-body approach could even shorten hospital stays, aiding recovery.

Overall, these studies suggest that intra-corporeal anastomosis is well-tolerated and offers a safe alternative for patients considering minimally invasive colon surgery.12345

Why are researchers excited about this trial?

Researchers are excited about intra-corporeal anastomosis in right hemicolectomy because it offers a minimally invasive approach that could enhance recovery for patients with colorectal disorders. Unlike traditional extra-corporeal methods, where the bowel is brought outside the body for reconnection, intra-corporeal anastomosis is performed internally. This technique may reduce surgical trauma, lower the risk of complications, and lead to quicker recovery times. By keeping the procedure within the body, there's potential for less pain and faster return to normal activities, which is why it's generating interest in the medical community.

What evidence suggests that intra-corporeal anastomosis is effective for colorectal disorders?

This trial will compare two techniques for minimally invasive right hemicolectomy: the internal connection technique (Intra-Corporeal Anastomosis) and the external connection technique (Extra-Corporeal). Research has shown that the internal connection technique can lead to faster recovery and fewer complications than the external connection technique. One study found that only 7.8% of patients using the internal method required additional surgeries, compared to 14.7% with the external method. Another analysis demonstrated that the internal technique significantly reduced overall complications and infection rates. It also lowered the risk of postoperative ileus, a condition where the bowel doesn't function properly after surgery. Overall, evidence suggests that the internal connection method could be a more effective option for a quicker and safer recovery.16789

Who Is on the Research Team?

JW

James Ogilvie, MS

Principal Investigator

Spectrum Health Hospitals

Are You a Good Fit for This Trial?

This trial is for adults over 18 who need a right hemicolectomy, which is surgery to remove part of the colon, using minimally invasive methods. It's not for prisoners, those unable to consent, emergency cases, pregnant women or if additional colon resection like left colectomy is planned.

Exclusion Criteria

My surgery is planned at Butterworth hospital.
I am scheduled for further surgery on my colon.
I had a loop ileostomy along with right side colon removal.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo a right hemicolectomy via a minimally invasive approach with intra-corporeal or extra-corporeal anastomosis

Surgery date
1 visit (in-person)

Postoperative Monitoring

Participants are monitored for return of bowel function and other secondary outcomes such as surgical site infection and postoperative narcotic use

up to 2 weeks
Daily monitoring during hospital stay

Follow-up

Participants are monitored for surgical site infection and perioperative morbidity

up to 6 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Intra-Corporeal Anastomosis
Trial Overview The study tests whether creating an anastomosis (connection between two parts of the intestine) inside the body after a right hemicolectomy leads to faster bowel function recovery and earlier hospital discharge compared to other methods.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Intra-corporealExperimental Treatment1 Intervention
Group II: Extra-corporealExperimental Treatment1 Intervention

Intra-Corporeal Anastomosis is already approved in European Union, United States, China for the following indications:

🇪🇺
Approved in European Union as Intracorporeal Anastomosis for:
🇺🇸
Approved in United States as Intracorporeal Anastomosis for:
🇨🇳
Approved in China as Intracorporeal Anastomosis for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Spectrum Health Hospitals

Lead Sponsor

Trials
66
Recruited
553,000+

Published Research Related to This Trial

Intracorporeal anastomosis (IA) during laparoscopic right hemicolectomy resulted in less intraoperative blood loss and shorter incision length compared to extracorporeal anastomosis (EA), indicating a potentially safer and less invasive approach.
Patients who underwent IA experienced faster recovery, with earlier postoperative bowel function and lower pain scores, while the overall complication rates were similar between IA and EA, suggesting IA may enhance patient comfort and recovery outcomes.
Intraoperative and postoperative short-term outcomes of intracorporeal anastomosis versus extracorporeal anastomosis in laparoscopic right hemicolectomy.Zhou, Y., Zhou, Y., Wang, C., et al.[2023]
In a study comparing 48 patients undergoing robotic-assisted intracorporeal anastomosis to 48 patients with standard extracorporeal anastomosis, the robotic group experienced significantly fewer complications, with no anastomotic complications or incisional hernias reported.
Patients in the robotic group also had a quicker recovery, with bowel function returning faster and a shorter hospital stay, indicating that robotic-assisted techniques may enhance postoperative outcomes in right hemicolectomy for cancer.
Robotic-assisted intracorporeal anastomosis versus extracorporeal anastomosis in laparoscopic right hemicolectomy for cancer: a case control study.Morpurgo, E., Contardo, T., Molaro, R., et al.[2022]
Intracorporeal ileocolic anastomosis (IA) during laparoscopic right hemicolectomy for colon cancer showed no significant difference in short- and long-term outcomes compared to extracorporeal anastomosis (EA), based on a study of 86 patients.
The IA technique had a lower conversion rate to open surgery (0% vs. 8.6% in EA), suggesting it may be a safer option, while both techniques had similar rates of complications and overall survival after 3 years.
Short- and long-term outcomes of intracorporeal versus extracorporeal ileocolic anastomosis in laparoscopic right hemicolectomy for colon cancer.Lee, KH., Ho, J., Akmal, Y., et al.[2021]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38850445/
A retrospective cohort study of intra-corporeal versus extra- ...ICA in laparoscopic right hemicolectomy is associated with quicker post-operative recovery and may be more cost effective compared with ECA, despite increased ...
A retrospective cohort study of intra-corporeal versus extra ...Laparoscopic right hemicolectomy has been demonstrated to result in quicker recovery and reduced complications, with comparable ...
Intracorporeal versus extracorporeal anastomosis in ...The rate of reoperation in the intracorporeal anastomosis group was 7.8%, whereas in the extracorporeal anastomosis group it was 14.7%. Of these cases, two ...
Review Article Intracorporeal Versus Extracorporeal Colo- ...The cumulative results of 8 included studies with 750 patients demonstrated a significant benefit of IA over EA in terms of overall morbidity, SSI, length of ...
Intracorporeal versus Extracorporeal Anastomosis in ...However, the intracorporeal anastomosis group had significantly lower rates of postoperative ileus (RR 0.67, 95% CI: 0.45–0.99, p = 0.04, I2 = ...
Intracorporeal Anastomosis in Right HemicolectomyThe ICA offers a comparable, safe alternative to ECA in laparoscopic right hemicolectomy. Reduced hospital stay is an added advantage.
Short-term outcomes for intracorporeal vs. extracorporeal ...The purpose of this study is to compare short-term outcomes and 1-year incisional hernia rates between intracorporeal anastomosis (IA) and ...
Current status of totally laparoscopic left hemicolectomy ...Numerous studies have confirmed that laparoscopic procedures offer superior therapeutic outcomes compared to traditional open surgery, improving ...
a retrospective cohort study of anastomotic complicationsShort- and long-term outcomes of intracorporeal versus extracorporeal ileocolic anastomosis in laparoscopic right hemicolectomy for colon cancer. Surg ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security